CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: lenvatinib
Accession: CHEBI:85994
browse the term
Definition: A member of the class of quinolines that is the carboxamide of 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxylic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine.
Synonyms: exact_synonym: 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide
related_synonym: 4-(3-Chloro-4-(N'-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide; E 7080; E7080; Formula=C21H19ClN4O4; InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28); InChIKey=WOSKHXYHFSIKNG-UHFFFAOYSA-N; SMILES=C=1(C(=CC2=C(C1)N=CC=C2OC3=CC(=C(C=C3)NC(NC4CC4)=O)Cl)C(N)=O)OC; UNII-EE083865G2
xref: CAS:417716-92-8; Drug_Central:4942; KEGG:D09919
xref_mesh: MESH:C531958
xref: PDBeChem:LEV; PMID:25240824; PMID:25458359; PMID:25589937; PMID:25600977; PMID:25616432; PMID:25625428; PMID:25671254; PMID:25720434; PMID:25795101; PMID:25859118; PMID:25913680; PMID:25974026; PMID:26008987; PMID:26026266; Reaxys:12096874; Wikipedia:Lenvatinib
cyclic_relationship: is_conjugate_base_of CHEBI:85998
G
Atp5f1a
ATP synthase F1 subunit alpha
affects expression
EXP
lenvatinib affects the expression of ATP5F1A protein
CTD
PMID:34019861
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Cat
catalase
decreases expression
EXP
lenvatinib results in decreased expression of CAT mRNA
CTD
PMID:34019861
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
affects expression
EXP
lenvatinib affects the expression of CDKN1A protein
CTD
PMID:34019861
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
EXP
lenvatinib results in decreased expression of CPT1A mRNA
CTD
PMID:35788046
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt1b
carnitine palmitoyltransferase 1B
decreases expression
EXP ISO
lenvatinib results in decreased expression of CPT1B mRNA; lenvatinib results in decreased expression of CPT1B protein
CTD
PMID:35788046
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression
EXP ISO
lenvatinib results in decreased expression of CPT2 mRNA; lenvatinib results in decreased expression of CPT2 protein
CTD
PMID:35788046
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Dnm1l
dynamin 1-like
increases expression
EXP
lenvatinib results in increased expression of DNM1L mRNA
CTD
PMID:34019861
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Fis1
fission, mitochondrial 1
increases expression
EXP
lenvatinib results in increased expression of FIS1 mRNA
CTD
PMID:34019861
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Lonp1
lon peptidase 1, mitochondrial
decreases expression
EXP
lenvatinib results in decreased expression of LONP1 protein
CTD
PMID:34019861
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases expression
EXP
lenvatinib results in increased expression of MAP3K5 mRNA
CTD
PMID:34019861
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mapk8
mitogen-activated protein kinase 8
increases expression
EXP
lenvatinib results in increased expression of MAPK8 mRNA
CTD
PMID:34019861
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mfn1
mitofusin 1
affects expression
EXP
lenvatinib affects the expression of MFN1 mRNA
CTD
PMID:34019861
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
G
Mfn2
mitofusin 2
affects expression
EXP
lenvatinib affects the expression of MFN2 mRNA
CTD
PMID:34019861
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
affects expression decreases expression
EXP
lenvatinib affects the expression of COX1 protein lenvatinib results in decreased expression of COX1 protein
CTD
PMID:34019861 PMID:35788046
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
affects expression
EXP
lenvatinib affects the expression of NDUFB8 protein
CTD
PMID:34019861
NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
EXP
lenvatinib results in decreased expression of NFE2L2 mRNA
CTD
PMID:34019861
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nrf1
nuclear respiratory factor 1
affects expression
EXP
lenvatinib affects the expression of NRF1 mRNA
CTD
PMID:34019861
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Opa1
OPA1, mitochondrial dynamin like GTPase
increases expression
EXP
lenvatinib results in increased expression of OPA1 mRNA
CTD
PMID:34019861
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Sdhb
succinate dehydrogenase complex iron sulfur subunit B
decreases expression
EXP
lenvatinib results in decreased expression of SDHB protein
CTD
PMID:34019861 PMID:35788046
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
G
Slc22a5
solute carrier family 22 member 5
decreases expression
ISO EXP
lenvatinib results in decreased expression of SLC22A5 protein lenvatinib results in decreased expression of SLC22A5 mRNA; lenvatinib results in decreased expression of SLC22A5 protein
CTD
PMID:35788046
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc25a20
solute carrier family 25 member 20
decreases expression
ISO EXP
lenvatinib results in decreased expression of SLC25A20 protein lenvatinib results in decreased expression of SLC25A20 mRNA; lenvatinib results in decreased expression of SLC25A20 protein
CTD
PMID:35788046
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Sod2
superoxide dismutase 2
increases expression
EXP
lenvatinib results in increased expression of SOD2 mRNA
CTD
PMID:34019861
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Ucp2
uncoupling protein 2
decreases expression
EXP
lenvatinib results in decreased expression of UCP2 mRNA; lenvatinib results in decreased expression of UCP2 protein
CTD
PMID:34019861
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
affects expression decreases expression
EXP
lenvatinib affects the expression of UQCRC2 protein lenvatinib results in decreased expression of UQCRC2 protein
CTD
PMID:34019861 PMID:35788046
NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all